Coronavirus Symptoms: New COVID wave, new symptoms? What doctors are noticing in recent cases
Tired of too many ads? go ad free now
While it doesn't appear to be more deadly than previous strains, it's definitely more contagious, which means more people can get sick in a shorter time, especially if they're not up-to-date on their vaccines.
Patients are presenting with typical flu symptoms along with gastrointestinal issues like nausea, diarrhea, and abdominal pain. So far, it doesn't appear to be a wave. The Omicron variant is mild, managed mostly on an outpatient basis, with very few requiring hospitalizations.
There's no clear pattern; everyone is getting affected. The fewer precautions you take, the more vulnerable you are. The virus can evade immunity, raising questions about vaccine effectiveness.
Since COVID is viral, confusion with other infections is common. However, with a systematic clinical assessment and targeted investigations, it's usually easy to differentiate. Most cases need no specific treatment, and many don't even realize they were infected.
Those with symptoms are treated conservatively using antipyretics and rest.
Post-COVID complications are rare. Given the low number of symptomatic cases, the incidence of complications is even lower. Prevention is key, being responsible helps protect others. Watch out for red flags like high fever over 104°F, difficulty in breathing, unrelenting cough, or confusion. If any of these occur, consult a nearby healthcare centre promptly.
Tired of too many ads? go ad free now
NB.1.8.1 hasn't triggered any global panic yet, but experts are watching it closely. Bottom line: it's not the worst variant we've seen, but it's a good reminder that COVID isn't totally done with us. Stay updated, stay cautious, and keep those hand sanitizers handy.
Dr Prasoon Srivastava Consultant physician and intensivist, K J Somaiya Hospital & Research Centre
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Maulana Azad dental science institute installs AI scanner to reduce wait time
New Delhi: Maulana Azad Institute of Dental Sciences (MAIDS) has installed ScanOair, an AI-powered scanner capable of detecting common dental issues such as tooth decay, gum inflammation and teeth misalignment to improve diagnostic efficiency and reduce patient waiting time. The device, which uses artificial intelligence to provide a provisional diagnosis within minutes, is being positioned as a patient-friendly innovation, especially beneficial in a high-volume setting like MAIDS. Final diagnosis and treatment planning, however, will continue to be handled by dental specialists following clinical evaluation, institute officials said. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi Speaking to TOI, Dr Gyanendra Kumar, professor and head of the department of comprehensive dentistry at MAIDS, said three ScanOair units have been installed on the ground floor near the registration counter and will be inaugurated on Wednesday by Delhi health minister Pankaj Kumar Singh. Each scanner costs approximately Rs 3 lakh. "The scanner is user-friendly and fully automated," Dr Kumar said. "Once the patient registers, they can select a preferred language, enter their name and WhatsApp number, and follow guided instructions. The machine adjusts its camera height, captures images from three angles — front, upper and lower — and generates a detailed AI-based report within five minutes." The scanner employs a three-layer AI system, detecting the mouth, jaw and appropriate camera angles. It also tilts to scan the roof of the mouth and identifies specific dental anomalies such as cavities, gum swelling, bleeding and even records body temperature. Patients receive a full PDF report on their WhatsApp, enabling them to consult doctors directly with the preliminary findings in hand. "With such a large OPD load, this system significantly reduces the time spent on routine oral examinations," Dr Kumar said, adding that assistants will be available to guide patients as needed. "Those who want to wait for a manual exam can still do so, but others can speed up the process with the scanner." Dr Arundeep Kaur, director principal of MAIDS, said the integration of ScanOair — supported by IDBI Bank under its CSR initiative — is a transformative step in streamlining care delivery. "It not only improves safety and efficiency in a post-COVID environment but also marks a major technological leap for govt dental institutions," she said.
Indian Express
2 hours ago
- Indian Express
Delhi sees spike in spurious drugs since Covid — BP meds, vitamins on list
Since the Covid-19 pandemic, Delhi has witnessed a surge in spurious drug cases, data from the Drug Control department has revealed. According to department officials, since September 2020, around 35 to 40 such cases have been moved against distributors in Delhi's sessions courts. 'Over the years, we have collected samples and seized fake drugs from 55 distributors, many of them repeat offenders,' said an official, adding that before the pandemic, the number of such cases was lower. Officials said that in 2020, the department had raided 4,511 units – places where a medicine is manufactured, packed, printed and sent for distribution – leading to the suspension or cancellation of licences of 369 units. The next year, the number of raids had increased to 5,041, and 480 licences were either cancelled or suspended. Since 2022, the number of such spurious cases has seen a slight decline. While in 2022, 4,281 units were raided and 304 had their licences cancelled or suspended, in 2023, raids were conducted at 3,806 units, of which licences of 327 were cancelled or suspended. Last year, 3,915 units were raided, of which licences of 443 were cancelled or suspended, said officials. The reason, said officials, was proactive enforcement of the law due to an increase in the department's manpower. 'In the last two years, manpower has been strengthened significantly as we needed more people to look into such cases,' the official said. Most of these dealers are based in Delhi, particularly Bhagirath Palace – a market famous for wholesale distribution of drugs, said officials. 'Delhi is a transit state from where vendors get drugs and send them to other states in North India,' the official said. According to records, many of the spurious drug cases were related to medicines for hypertension, cholesterol, dermatitis and allergy, as well as Calcium and Vitamin supplements. 'These vendors also deal in spurious sanitisers, toothpaste, almond oil, injections and nutritional supplements such as Nilcobal Tablets. In many instances, plastic transparent bottles filled with transparent liquid are distributed without any label or expiry date,' the official said. On why the number of cases saw a rise in the Covid-19 years, an official said, 'Advancement in technology when it comes to printing and packaging, often makes it difficult to differentiate between spurious and real drugs.' Another reason behind the surge is the decentralisation of manufacturing units, the official added. 'Earlier, companies used to manufacture and distribute drugs from one destination. Now, printing, stripping and blistering of medicines takes place at different areas… in many cases, even in different states… making identification of spurious drugs a challenge.' Top six medicines linked to spurious drug cases Telma 40: Hypertension Shelcal: Calcium and Vitamin D3 supplement Rosuvas 10: Cholesterol and Triglyceride Betnovate N cream: Eczema, Psoriasis, Dermatitis Rosuvas F 20: Cholesterol, triglyceride Montek LC: Allergic symptoms
Time of India
2 hours ago
- Time of India
Kids with heart conditions must get timely, quality treatment: Ukesh
Mysuru: Mysuru zilla panchayat CEO S Ukesh Kumar on Tuesday stressed the need to strengthen the Rashtriya Bal Swasthya Karyakram (RBSK) and improve healthcare services for anganwadi and schoolchildren suffering from health issues. He emphasised that children referred for advanced treatment must be consistently followed up, ensuring their treatment is completed without delay. He was speaking at the district-level review meeting of national health programmes, held at Anubhava Mantapa auditorium, district health office. "Children with heart conditions must receive timely, quality treatment at super specialty hospitals. Early detection and management of health issues among children through regular check-ups at schools and anganwadi centres are crucial to reducing infant mortality," he said. Highlighting preventable infant deaths, he instructed taluk health officers to conduct facility and community-level reviews and submit taluk-wise reports, along with actionable recommendations. Regarding maternal deaths, he directed officials to seek reports from the district-level technical expert committee and initiate action against responsible parties where necessary. Calling for full implementation of the Kayakalp programme in 2025-26, Kumar asked health officials to review pending tasks and achieve 100% progress in internal, state, and national assessments within the next three months. He recommended including health progress discussions in monthly panchayat development officer (PDO) meetings and monthly revenue department reviews chaired by the deputy commissioner. The CEO also emphasised strict compliance with biomedical waste management protocols at Ayushman Arogya Mandirs and directed regular monitoring of Covid-19, influenza H1N1, dog bite, and snakebite cases under the Integrated Disease Surveillance Programme (IDSP). 75 TB-related deaths Reviewing TB control efforts from Jan to June 2025, Kumar noted 75 TB-related deaths with a 7% mortality rate. He directed officials to reduce this below 5% and submit death audit reports without fail. Under the National Leprosy Eradication Programme, 78 active cases were reported in the district, primarily in T Narsipura, Nanjangud, and Mysuru city areas. Officials were asked to intensify weekly surveys and report suspected cases immediately.
